Heart Attack Diagnostics Market Size, Share & Industry Analysis, By Type (Minimally Invasive, Non-Invasive), By Test (Electrocardiography, Blood Tests, Computerized Cardiac Tomography, Echocardiography, Coronary Angiography, Others (Chest X-ray, Cardiac CT)), By End User (Hospitals & Clinics, Diagnostics Centres, Ambulatory Surgical Centres) And Regional Forecast, 2024-2032

Heart attack is a condition characterized by blockage in one or more arteries that supply blood and oxygen to the heart.  Unhealthy lifestyles, including excess alcohol drinking, cigarette smoking, and fast food consumption, are the major causes of a heart attack. Adopting these unhealthy lifestyles is responsible for the increase in heart attack incidence among the population. Moreover, the rise in the geriatric population leads to an increase in heart attack conditions because the aging population is more susceptible to heart diseases. These factors are attributed to the growing prevalence of cardiovascular diseases globally. Furthermore, other medical conditions are also responsible for heart attack, such as the patient with kidney failure is more susceptible to a heart attack. Additionally, there are several diagnostics procedures available for the diagnosis of a heart attack. Thus, technological advancement is adding more value to these diagnostic procedures. For instance, the rising use of artificial intelligence in diagnostics instruments. These technological advancements are also responsible for the growth of the heart attack diagnostics market. However, there are some factors like cost of diagnostics procedures, and lack of trained professional are restraining the growth of the market.

Market Segmentation:

Globally, the heart attack diagnostics market can be segmented on the basis of type, test, end user and geography. Based on the type, the market can be segmented into minimally invasive and non-invasive. Based on test the market is segmented into electrocardiography, blood tests, computerized cardiac tomography, echocardiography, coronary angiography and others. Based on end user, the market is segmented into hospitals and clinics, diagnostics centers and ambulatory surgical centers. Geographically, the heart attack diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the heart attack diagnostics market are GENERAL ELECTRIC, FUJIFILM Holdings, Koninklijke Philips N.V., Midmark Corporation, F. Hoffmann-La Roche Ltd, SCHILLER, Beckman Coulter, Inc., Toshiba Corporation, Hill-Rom Services (Welch Allyn), Abbott and other prominent players.

Key Insights: 

• Key Industry Trends


• Technological Advancements in Heart Attack Diagnostics


• New Product Launches


• Key Industry Developments Mergers, Acquisitions, And Collaborations


• Impact of COVID-19 on Heart Attack Diagnostics Market

Regional Analysis:

Geographically, the heart attack diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is anticipated to account for the majority of the share of the heart attack diagnostics market. There are various factors are responsible for the dominance of the region, such as the growing prevalence of cardiac diseases, well-developed healthcare infrastructure, and presence of key players in this region. Furthermore, the increase in the prevalence of diabetes & obesity and technological advancement like enabled portability features in performing tests makes Europe the second-largest shareholder in this market. On the other hand, Asia Pacific is expected to grow with the highest growth rate during the forecast period due to the rising number of cardiac patient populations and developing healthcare infrastructure. The market in Latin America and the Middle East & Africa are expected to showcase sluggish growth during the forecast period, countries in this region lacking healthcare diagnostic infrastructure and funding for the research.

Segmentation

Heart Attack Diagnostics Market Industry Developments:

• July 2021, Canon Medical & Cleerly are going in partnership to support the adoption of Cardiac CT and creating a new standard of care in heart disease. This partnership will bring major advancements in the cardiac diagnostics industry.

• June 2021, Idorsia initiates the phase 3 registration study with selatogrel. Selatogrel can become the option for aspirin. In phase 3, efficacy and safety of selatogrel will be evaluated. It will prevent many deaths due to heart attacks.